Iowa Code § 124.552
This is the official text of Iowa Code § 124.552, part of Iowa’s Code — part of the compiled statutory law of Iowa, published by the state as "Code." Browse the sections below, each linked to its official government source.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
Information reporting.
Official statutory text
(1) Unless otherwise prohibited by federal or state law, each licensed pharmacy that dispenses controlled substances identified pursuant to section 124.554, subsection 1, paragraph “g”, to patients in the state, each licensed pharmacy located in the state that dispenses such controlled substances identified pursuant to section 124.554, subsection 1, paragraph “g”, to patients inside or outside the state, unless specifically excepted in this section or by rule, and each prescribing practitioner furnishing, dispensing, or supplying controlled substances to the prescribing practitioner’s patient, shall submit the following prescription information to the program:
(1) (a) Pharmacy identification.
(1) (b) Patient identification.
(1) (c) Prescribing practitioner identification.
(1) (d) The date the prescription was issued by the prescribing practitioner.
(1) (e) The date the prescription was dispensed.
(1) (f) An indication of whether the prescription dispensed is new or a refill.
(1) (g) Identification of the drug dispensed.
(1) (h) Quantity of the drug dispensed.
(1) (i) The number of days’ supply of the drug dispensed.
(1) (j) Serial or prescription number assigned by the pharmacy.
(1) (k) Type of payment for the prescription.
(1) (l) Other information identified by the board by rule.
(2) Information shall be submitted electronically in a secure format specified by the board unless the board has granted a waiver and approved an alternate secure format.
(3) Information shall be timely transmitted within one business day of the dispensing of the controlled substance, unless the board grants an extension. The board may grant an extension if either of the following occurs:
(3) (a) The pharmacy or prescribing practitioner suffers a mechanical or electronic failure, or cannot meet the deadline established by the board for other reasons beyond the pharmacy’s or practitioner’s control.
(3) (b) The board is unable to receive electronic submissions.
(4) This section shall not apply to dispensing by a licensed pharmacy for the purposes of inpatient hospice care or long-term residential facility patient care.
2006 Acts, ch 1147, §3, 11; 2007 Acts, ch 126, §25, 26; 2018 Acts, ch 1138, §5
(1) (a) Pharmacy identification.
(1) (b) Patient identification.
(1) (c) Prescribing practitioner identification.
(1) (d) The date the prescription was issued by the prescribing practitioner.
(1) (e) The date the prescription was dispensed.
(1) (f) An indication of whether the prescription dispensed is new or a refill.
(1) (g) Identification of the drug dispensed.
(1) (h) Quantity of the drug dispensed.
(1) (i) The number of days’ supply of the drug dispensed.
(1) (j) Serial or prescription number assigned by the pharmacy.
(1) (k) Type of payment for the prescription.
(1) (l) Other information identified by the board by rule.
(2) Information shall be submitted electronically in a secure format specified by the board unless the board has granted a waiver and approved an alternate secure format.
(3) Information shall be timely transmitted within one business day of the dispensing of the controlled substance, unless the board grants an extension. The board may grant an extension if either of the following occurs:
(3) (a) The pharmacy or prescribing practitioner suffers a mechanical or electronic failure, or cannot meet the deadline established by the board for other reasons beyond the pharmacy’s or practitioner’s control.
(3) (b) The board is unable to receive electronic submissions.
(4) This section shall not apply to dispensing by a licensed pharmacy for the purposes of inpatient hospice care or long-term residential facility patient care.
2006 Acts, ch 1147, §3, 11; 2007 Acts, ch 126, §25, 26; 2018 Acts, ch 1138, §5
Status: in_force · Read it on the official government site
Need a lawyer in Iowa?
Find a Iowa lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.